DK3157506T3 - Smagsmaskeret oral, farmaceutisk sammensætning - Google Patents

Smagsmaskeret oral, farmaceutisk sammensætning Download PDF

Info

Publication number
DK3157506T3
DK3157506T3 DK15729517.1T DK15729517T DK3157506T3 DK 3157506 T3 DK3157506 T3 DK 3157506T3 DK 15729517 T DK15729517 T DK 15729517T DK 3157506 T3 DK3157506 T3 DK 3157506T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
taste masked
masked oral
oral
taste
Prior art date
Application number
DK15729517.1T
Other languages
English (en)
Inventor
Klaus Dandl
Karin Becker
Behzadi Sharareh Salar
Detlev Haack
Claudia Lang
Andreas Zimmer
Original Assignee
Hermes Arzneimittel Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hermes Arzneimittel Gmbh filed Critical Hermes Arzneimittel Gmbh
Application granted granted Critical
Publication of DK3157506T3 publication Critical patent/DK3157506T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
DK15729517.1T 2014-06-20 2015-06-19 Smagsmaskeret oral, farmaceutisk sammensætning DK3157506T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14173273 2014-06-20
PCT/EP2015/063841 WO2015193485A1 (en) 2014-06-20 2015-06-19 Taste-masked oral pharmaceutical composition

Publications (1)

Publication Number Publication Date
DK3157506T3 true DK3157506T3 (da) 2020-11-23

Family

ID=50972591

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15729517.1T DK3157506T3 (da) 2014-06-20 2015-06-19 Smagsmaskeret oral, farmaceutisk sammensætning

Country Status (10)

Country Link
US (1) US10314801B2 (da)
EP (1) EP3157506B1 (da)
DK (1) DK3157506T3 (da)
ES (1) ES2829644T3 (da)
HR (1) HRP20201863T1 (da)
HU (1) HUE051900T2 (da)
PL (1) PL3157506T3 (da)
PT (1) PT3157506T (da)
SI (1) SI3157506T1 (da)
WO (1) WO2015193485A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012027222A1 (en) 2010-08-24 2012-03-01 Rutgers, The State University Of New Jersey Formulation and manufacture of pharmaceuticals by impregnation onto porous carriers
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN117598506A (zh) * 2019-09-12 2024-02-27 努利希尔有限公司 受控释放的核-壳粒子及包含其的悬浮液
WO2021084030A1 (en) 2019-10-31 2021-05-06 Hermes Arzneimittel Gmbh Oral pharmaceutical composition comprising a melt-agglomerated active ingredient core
US20230114357A1 (en) * 2020-03-17 2023-04-13 Rutgers,The State University Of New Jersey Continuous melt-coating of active pharmaceutical ingredients using surfactants for dissolution enhancement

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4687662A (en) 1985-08-30 1987-08-18 Warner-Lambert Company Therapeutic effervescent composition
CH677606A5 (da) * 1988-07-12 1991-06-14 Aesculapius Pharma Sa
DE3838431A1 (de) 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
MX9300110A (es) 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
US5728403A (en) * 1994-10-05 1998-03-17 The Board Of Regents Of The University Of Nebraska Coating technology for taste masking orally administered bitter drugs
US6274172B1 (en) 1995-07-05 2001-08-14 Smithkline Beecham Laboratoires Pharmaceutiques Therapeutic effervescent compositions
DE839528T1 (de) 1996-10-29 1998-10-22 Staroil Ltd Mundlösliche Zusammensetzungen die N-Acetylcystein und Cyclodextrin enthalten
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
US20060034937A1 (en) 1999-11-23 2006-02-16 Mahesh Patel Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
JP3368898B1 (ja) * 2002-01-24 2003-01-20 味の素株式会社 分岐鎖アミノ酸含有顆粒の製造方法
FR2851918B1 (fr) 2003-03-06 2006-06-16 Poudre impregnee ameliorant la biodisponibilite et/ou la solubilite et procede de fabrication
JP5054940B2 (ja) 2005-07-19 2012-10-24 ロート製薬株式会社 錠剤組成物
JP5160779B2 (ja) 2005-12-28 2013-03-13 全薬工業株式会社 攪拌型造粒機を用いた製剤の製造方法
DE102006059510A1 (de) 2006-12-14 2008-06-19 Grünenthal GmbH Beschichtete Pellets
ITPD20070049A1 (it) 2007-02-14 2008-08-15 Sila S R L Prodotto a base di acido linoleico coniugato e processo per la sua fabbricazione
AR071375A1 (es) 2008-04-22 2010-06-16 Solvay Pharm Gmbh Formulaciones para ingredientes farmaceuticos activos de permeabilidad deficiente, proceso de preparacion y producto
EP2172191A1 (en) 2008-10-01 2010-04-07 Heinrich-Heine-Universität Düsseldorf Lipid pellets with enhanced taste-masking
EP2198859A1 (en) * 2008-12-17 2010-06-23 Losan Pharma GmbH Melt-coated pharmaceutical composition with fast release
EP2379057B1 (en) 2008-12-19 2013-07-17 Novartis AG Phenylephrine formulations with improved stability
AR079862A1 (es) * 2010-01-08 2012-02-22 Eurand Inc Composicion de topiramato con sabor enmascarado, un comprimido desintegrable oralmente que comprende la misma y metodo de preparacion
KR20140097135A (ko) 2011-09-27 2014-08-06 버지니아 커먼웰스 유니버시티 페닐에프린 및 다른 페놀계 생물활성제의 경구 생물학적 이용효능을 증가시키기 위한 선택적인 대사적 접근법
EP2953617B1 (en) 2013-02-06 2019-10-02 Hermes Arzneimittel GmbH Pharmaceutical compositions incorporating low-dose drugs
PT2983650T (pt) * 2013-04-12 2017-09-01 Hermes Arzneimittel Gmbh Composição farmacêutica oral compreendendo n-acetilcisteína com ocultação de sabor

Also Published As

Publication number Publication date
SI3157506T1 (sl) 2021-01-29
EP3157506B1 (en) 2020-08-26
WO2015193485A1 (en) 2015-12-23
HRP20201863T1 (hr) 2021-01-22
PT3157506T (pt) 2020-11-17
EP3157506A1 (en) 2017-04-26
ES2829644T3 (es) 2021-06-01
HUE051900T2 (hu) 2021-03-29
US20170157049A1 (en) 2017-06-08
US10314801B2 (en) 2019-06-11
PL3157506T3 (pl) 2021-03-08

Similar Documents

Publication Publication Date Title
HK1243999A1 (zh) 新型3-吲哚取代的衍生物、藥物組合物及使用方法
BR112016023628A2 (pt) composições farmacêuticas.
DK3297605T3 (da) Topiske, farmaceutiske sammesætninger
DK3089741T3 (da) Farmaceutiske sammensætninger omfattende azd9291
GB201409471D0 (en) Pharmaceutical composition
BR112016018062A2 (pt) compostos terapêuticos, composição farmacêutica e usos
DK3229816T3 (en) Proton-bindende polymerer til oral administration
DK3223796T3 (da) Farmaceutiske sammensætninger, fremstilling og anvendelser deraf
DK3199161T3 (da) Farmaceutisk præparat
GB201409485D0 (en) Pharmaceutical composition
GB201409488D0 (en) Pharmaceutical composition
ZA201702086B (en) Long acting pharmaceutical compositions
DK3383397T3 (da) Farmaceutiske sammensætninger indeholdende doravirin, tenofovirdisoproxilfumarat og lamivudin
DK3157506T3 (da) Smagsmaskeret oral, farmaceutisk sammensætning
DK3389633T3 (da) Farmaceutiske sammensætninger, der omfatter phenylaminopyrimidinderivat
DK3229843T3 (da) Farmaceutisk sammensætning, præparat og anvendelser deraf
ZA201502073B (en) Pharmaceutical composition
DK3313370T3 (da) Oftalmologisk farmaceutisk sammensætning
ZA201508726B (en) Pharmaceutical composition
KR20180084728A (ko) 구강용 조성물
DK3288967T3 (da) Farmaceutisk forbindelse
DK3089740T3 (da) Farmaceutisk sammensætning
DK2915526T3 (da) Farmaceutiske sammensætninger, der omfatter anagrelid
DK3424500T3 (da) Farmaceutisk sammensætning, der omfatter famitinib
SG10201504332VA (en) Pharmaceutical Composition